Valuation: Vystar Corporation

Market Cap 2.33M 2.07M 1.93M 1.76M 3.32M 224M 3.35M 23.4M 9.07M 115M 8.75M 8.56M 368M P/E 2024
0.63x
P/E 2025 -0.58x
Enterprise Value 3.41M 3.03M 2.83M 2.58M 4.86M 328M 4.91M 34.22M 13.26M 168M 12.8M 12.52M 538M EV / Sales 2024
13.1x
EV / Sales 2025 39.9x
Free-Float
93.05%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 58 21/12/2023
Director TitleAgeSince
Director/Board Member 58 17/12/2017
Chairman 46 14/02/2018
Director/Board Member 71 25/01/2021
Change 5-day change 1-year change 3-year change Capi.($)
-1.03%-4.67% - - 2.33M
+1.26%-1.15%-6.97%+32.79% 81.72B
+1.25%-1.20%-6.51%+46.37% 64.17B
+2.10%-1.12%-11.81%+15.08% 38.77B
+0.08%-2.53%-11.63%+21.70% 23.08B
+1.92%+1.75%+39.49%+95.91% 16.81B
+3.98%+0.18%-8.01%+37.67% 15.15B
+3.00%-0.48% - - 12.56B
+1.01%+1.42%+7.31%+48.89% 10.28B
-1.78%-2.33%-1.84%+7.71% 8.48B
Average +1.18%-0.61%+0.00%+38.27% 30.11B
Weighted average by Cap. +1.45%-0.93%-4.30%+36.73%

Financials

2024 2025
Net sales 136K 121K 113K 103K 194K 13.07M 196K 1.36M 529K 6.68M 510K 499K 21.45M 54.82K 48.71K 45.46K 41.44K 78.15K 5.27M 78.88K 550K 213K 2.69M 206K 201K 8.65M
Net income 760K 675K 630K 574K 1.08M 73.01M 1.09M 7.62M 2.95M 37.33M 2.85M 2.79M 120M -1.53M -1.36M -1.27M -1.16M -2.18M -147M -2.2M -15.37M -5.96M -75.27M -5.75M -5.63M -242M
Net Debt 1.15M 1.02M 955K 870K 1.64M 111M 1.66M 11.55M 4.48M 56.57M 4.32M 4.23M 182M 1.08M 958K 894K 815K 1.54M 104M 1.55M 10.82M 4.19M 52.97M 4.05M 3.96M 170M
Logo Vystar Corporation
Vystar Corporation is the owner and manufacturer of multiple brands of eco-friendly products for the home, office and medical sectors. The Company is focused on three main brands: Vytex, RXAIR, and Fluid Energy Conversion (FEC). The Company uses patented technology to produce a line of air purifiers, which destroy viruses and bacteria through the use of ultraviolet light. It is also the creator and owner of Vytex Natural Rubber Latex (NRL), being used primarily in toppers and in various bedding products. RxAir is the manufacturer of air purification systems in the world and a developer, manufacturer and distributor of biotechnology products targeting the indoor air quality (IAQ) industry sector. RxAir’s products include the RxAir purification system for the home as well as lines of hospital-grade HEPA filtration products. All of its products are Food and Drug Administration (FDA) certified as Class II medical devices and kill germs, viruses and bacteria.
Employees
-